IL64243A - Hybrid human leukocyte interferon type anti-viral polypeptides,their preparation by genetic engineering methods and pharmaceutical compositions containing them - Google Patents
Hybrid human leukocyte interferon type anti-viral polypeptides,their preparation by genetic engineering methods and pharmaceutical compositions containing themInfo
- Publication number
- IL64243A IL64243A IL64243A IL6424381A IL64243A IL 64243 A IL64243 A IL 64243A IL 64243 A IL64243 A IL 64243A IL 6424381 A IL6424381 A IL 6424381A IL 64243 A IL64243 A IL 64243A
- Authority
- IL
- Israel
- Prior art keywords
- human leukocyte
- preparation
- pharmaceutical compositions
- compositions containing
- genetic engineering
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
- C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20557980A | 1980-11-10 | 1980-11-10 | |
US06/237,388 US4414150A (en) | 1980-11-10 | 1981-02-23 | Hybrid human leukocyte interferons |
US06/305,657 US4456748A (en) | 1981-02-23 | 1981-09-25 | Hybrid human leukocyte interferons |
Publications (2)
Publication Number | Publication Date |
---|---|
IL64243A0 IL64243A0 (en) | 1982-02-28 |
IL64243A true IL64243A (en) | 1985-11-29 |
Family
ID=27394813
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL64243A IL64243A (en) | 1980-11-10 | 1981-11-09 | Hybrid human leukocyte interferon type anti-viral polypeptides,their preparation by genetic engineering methods and pharmaceutical compositions containing them |
Country Status (34)
Country | Link |
---|---|
EP (1) | EP0051873B1 (es) |
JP (1) | JP2642291B2 (es) |
KR (1) | KR920007439B1 (es) |
AT (1) | ATE46718T1 (es) |
AU (1) | AU555293B2 (es) |
BR (1) | BR8107293A (es) |
CA (2) | CA1212915A (es) |
CH (2) | CH660743A5 (es) |
DE (2) | DE3177106D1 (es) |
DK (1) | DK173590B1 (es) |
DO (1) | DOP1981004064A (es) |
DZ (1) | DZ350A1 (es) |
ES (2) | ES506955A0 (es) |
FI (1) | FI79550C (es) |
FR (1) | FR2493867B1 (es) |
GB (1) | GB2090258B (es) |
GR (1) | GR81947B (es) |
HK (1) | HK51685A (es) |
IE (1) | IE51850B1 (es) |
IL (1) | IL64243A (es) |
IT (1) | IT1169276B (es) |
KE (1) | KE3536A (es) |
LU (1) | LU83745A1 (es) |
MC (1) | MC1424A1 (es) |
MY (2) | MY8700710A (es) |
NL (1) | NL189092C (es) |
NO (1) | NO165201C (es) |
NZ (1) | NZ198906A (es) |
PH (1) | PH18565A (es) |
PL (1) | PL233748A1 (es) |
PT (1) | PT73955B (es) |
SE (1) | SE460539B (es) |
YU (1) | YU46597B (es) |
ZW (1) | ZW26981A1 (es) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH657141A5 (de) * | 1980-07-01 | 1986-08-15 | Hoffmann La Roche | Dns-sequenzen, rekombinante expressionsvektoren zur mikrobiellen herstellung von human-leukozyten-interferonen und transformierte mikroorganismen. |
EP0072541A3 (en) * | 1981-08-14 | 1984-04-18 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | Human leukocyte interferons, process for their microbial production, intermediates therefor and compositions containing them |
EP0085693A1 (en) * | 1981-08-14 | 1983-08-17 | A/S Alfred Benzon | Subjects relating to human inteferon-alpha subtype proteins and corresponding antibodies |
GB2108510B (en) * | 1981-10-03 | 1984-12-12 | Ciba Geigy Ag | Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof |
WO1983002461A1 (en) * | 1982-01-19 | 1983-07-21 | Cetus Corp | Multiclass hybrid interferons |
DE3220116A1 (de) * | 1982-05-28 | 1983-12-01 | Dr. Karl Thomae Gmbh, 7950 Biberach | Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung |
CA1252046A (en) * | 1982-11-04 | 1989-04-04 | Martin J. Cline | Methods for oncogenic detection |
WO1984003300A1 (en) * | 1983-02-24 | 1984-08-30 | Inst Organicheskogo Sinteza Ak | Leukocytic human interferon n and method to obtain it in bacterial cells |
GB8315980D0 (en) * | 1983-06-10 | 1983-07-13 | Biogen Nv | Producing hybrid dna sequences |
GB8317880D0 (en) * | 1983-07-01 | 1983-08-03 | Searle & Co | Structure and synthesis of interferons |
US4892743A (en) * | 1983-12-21 | 1990-01-09 | Schering Corporation | Novel hybrid interferon species |
EP0146903A3 (en) * | 1983-12-19 | 1987-07-22 | Schering Corporation | Production of a vector encoding a novel hybrid interferon species |
DE3409966A1 (de) * | 1984-03-19 | 1985-09-26 | Hoechst Ag, 6230 Frankfurt | Gentechnologisches verfahren zur herstellung von human-gammainterferon und mittel zur durchfuehrung dieses verfahrens |
JPS6156199A (ja) * | 1984-08-27 | 1986-03-20 | Shionogi & Co Ltd | 新規ヒトインタ−フエロンα類 |
EP0173935A1 (en) * | 1984-08-31 | 1986-03-12 | University Patents, Inc. | Hybrid lymphoblastoid-leukocyte human interferons |
DE3434345A1 (de) * | 1984-09-19 | 1986-03-27 | Hoechst Ag, 6230 Frankfurt | Verwendung von (alpha)-interferonen zur bekaempfung von durchfaellen |
DE3685044D1 (de) * | 1985-02-01 | 1992-06-04 | Ici Plc | Analoge interferon-polypeptide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. |
EP0205404B1 (en) * | 1985-06-11 | 1992-07-15 | Ciba-Geigy Ag | Hybrid interferons |
EP0240550A4 (en) * | 1985-09-26 | 1989-09-19 | Genetics Inst | LUNG SURFACE ACTIVE PROTEINS. |
US4806347A (en) * | 1985-12-11 | 1989-02-21 | Schering Corporation | Interferon combinations |
DE3607835A1 (de) * | 1986-03-10 | 1987-09-24 | Boehringer Ingelheim Int | Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung |
EP0490233A1 (de) * | 1986-03-10 | 1992-06-17 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Monoclonale Antikörper gegen BgIII-Hybridinterferone, deren Verwendung und Verfahren zu ihrer Herstellung |
US4851220A (en) * | 1986-11-26 | 1989-07-25 | Schering Corporation | Stable oleaginous gel |
US4853218A (en) * | 1987-02-24 | 1989-08-01 | Schering Corporation | Zinc-protamine-alpha interferon complex |
EP0331635A3 (en) * | 1988-02-29 | 1990-02-28 | The Board of Regents of the University of Texas System | Preparations for treating bladder cancer |
US5372808A (en) † | 1990-10-17 | 1994-12-13 | Amgen Inc. | Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect |
GB2273931A (en) * | 1992-09-28 | 1994-07-06 | Unilever Plc | Mutant polypeptides |
US6251939B1 (en) | 1995-06-07 | 2001-06-26 | Promega Biosciences, Inc. | Carbamate-based cationic lipids |
TW442492B (en) * | 1995-07-26 | 2001-06-23 | Novartis Ag | Process for the enrichment of interferon |
FR2823220B1 (fr) | 2001-04-04 | 2003-12-12 | Genodyssee | Nouveaux polynucleotides et polypeptides de l'erythropoietine (epo) |
US7314613B2 (en) | 2002-11-18 | 2008-01-01 | Maxygen, Inc. | Interferon-alpha polypeptides and conjugates |
TW200611910A (en) | 2004-05-19 | 2006-04-16 | Maxygen Inc | Interferon-alpha polypeptides and conjugates |
CA2607651A1 (en) | 2005-05-18 | 2007-04-19 | Maxygen, Inc. | Evolved interferon-alpha polypeptides |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO164037C (no) * | 1980-01-08 | 1990-08-22 | Biogen Inc | Fremgangsmaate ved fremstilling av et polypeptid av interferon alfa (ifnalfa)-type. |
-
1981
- 1981-11-07 ES ES506955A patent/ES506955A0/es active Granted
- 1981-11-09 FR FR8120943A patent/FR2493867B1/fr not_active Expired
- 1981-11-09 MC MC811558A patent/MC1424A1/xx unknown
- 1981-11-09 CH CH7174/81A patent/CH660743A5/de not_active IP Right Cessation
- 1981-11-09 AT AT81109579T patent/ATE46718T1/de not_active IP Right Cessation
- 1981-11-09 DE DE8181109579T patent/DE3177106D1/de not_active Expired
- 1981-11-09 DK DK198104946A patent/DK173590B1/da active
- 1981-11-09 EP EP81109579A patent/EP0051873B1/en not_active Expired
- 1981-11-09 PL PL23374881A patent/PL233748A1/xx unknown
- 1981-11-09 CA CA000389688A patent/CA1212915A/en not_active Expired
- 1981-11-09 DE DE19813144469 patent/DE3144469A1/de not_active Ceased
- 1981-11-09 AU AU77304/81A patent/AU555293B2/en not_active Expired
- 1981-11-09 NO NO813785A patent/NO165201C/no not_active IP Right Cessation
- 1981-11-09 CH CH5574/85A patent/CH663032A5/de not_active IP Right Cessation
- 1981-11-09 PH PH26462A patent/PH18565A/en unknown
- 1981-11-09 GB GB8133762A patent/GB2090258B/en not_active Expired
- 1981-11-09 PT PT73955A patent/PT73955B/pt unknown
- 1981-11-09 NZ NZ198906A patent/NZ198906A/en unknown
- 1981-11-09 IL IL64243A patent/IL64243A/xx not_active IP Right Cessation
- 1981-11-09 GR GR66464A patent/GR81947B/el unknown
- 1981-11-09 IE IE2622/81A patent/IE51850B1/en not_active IP Right Cessation
- 1981-11-09 SE SE8106641A patent/SE460539B/sv not_active Application Discontinuation
- 1981-11-09 DZ DZ816369A patent/DZ350A1/fr active
- 1981-11-10 IT IT24967/81A patent/IT1169276B/it active
- 1981-11-10 BR BR8107293A patent/BR8107293A/pt unknown
- 1981-11-10 NL NLAANVRAGE8105078,A patent/NL189092C/xx not_active IP Right Cessation
- 1981-11-10 KR KR1019810004343A patent/KR920007439B1/ko active
- 1981-11-10 LU LU83745A patent/LU83745A1/de unknown
- 1981-11-10 ZW ZW269/81A patent/ZW26981A1/xx unknown
- 1981-11-10 FI FI813539A patent/FI79550C/fi not_active IP Right Cessation
- 1981-11-10 YU YU265681A patent/YU46597B/sh unknown
- 1981-11-10 DO DO1981004064A patent/DOP1981004064A/es unknown
-
1982
- 1982-05-19 ES ES512354A patent/ES512354A0/es active Granted
-
1984
- 1984-12-18 CA CA000470467A patent/CA1277616C/en not_active Expired - Lifetime
-
1985
- 1985-05-21 KE KE3536A patent/KE3536A/xx unknown
- 1985-07-04 HK HK516/85A patent/HK51685A/xx not_active IP Right Cessation
-
1987
- 1987-12-30 MY MY710/87A patent/MY8700710A/xx unknown
-
1988
- 1988-12-30 MY MY66/88A patent/MY8800066A/xx unknown
-
1992
- 1992-12-28 JP JP4349148A patent/JP2642291B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL64243A (en) | Hybrid human leukocyte interferon type anti-viral polypeptides,their preparation by genetic engineering methods and pharmaceutical compositions containing them | |
ES8207514A1 (es) | Un procedimiento para la preparacion de interferon | |
SE8105657L (sv) | Mikrobiell framstellning av humanfibroblastinterferon | |
ZA81975B (en) | Microbiologically prepared polypeptide with the aminoacid sequence of human interferon, dna and plasmids which act as codings for this sequence, microorganisms which contain this genetic information, and processes for their preparation | |
NZ212937A (en) | Omega interferons: production by recombinant dna processes; pharmaceutical compositions | |
EP0072541A3 (en) | Human leukocyte interferons, process for their microbial production, intermediates therefor and compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB | Patent renewed | ||
KB | Patent renewed | ||
EXP | Patent expired |